Englewood, NJNCT06937996Now EnrollingIRB Ready

Pancreatic Cancer Non-resectable Clinical Trial in Englewood, NJ

Access cutting-edge pancreatic cancer non-resectable treatment through this clinical trial at a research site in Englewood. Study-provided care at no cost to qualified participants.

Sponsored by Englewood Hospital and Medical Center

Quick Self-Assessment

See if you qualify for this Englewood location

Preparing your pre-screening questions…

Expert Care in Englewood

Access pancreatic cancer non-resectable specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related pancreatic cancer non-resectable treatment provided free

Apply for This Englewood Location

Check if you qualify for this pancreatic cancer non-resectable clinical trial in Englewood, NJ

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Englewood

    Convenient for NJ residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Englewood site if eligible
  4. 4Begin participation

About This Pancreatic Cancer Non-resectable Study in Englewood

The purpose of this study is to evaluate the short and intermediate term safety of the NanoKnife Irreversible Electroporation System when used off-label to treat unresectable pancreatic cancer. In addition, the study will evaluate the efficacy of this device in treating pain associated with unresectable pancreatic cancer. Quality of life post-procedure will also be collected.

Sponsor: Englewood Hospital and Medical Center

Who Can Participate

Inclusion Criteria

\> = 18 years of age
Must be found to have locally advanced unresectable disease following standard chemotherapy ± radiotherapy as demonstrated with either CT/MRI imaging and surgical evaluation, and not have taken any chemotherapy/radiotherapy within 5 weeks of treatment with the NanoKnife IRE System
Must have an INR \< 1.5
Are willing and able to comply with the protocol requirements
Are able to comprehend and willing to sign an informed consent form

Exclusion Criteria

Creatinine \> 2.0 mg/dL
Any lab value with a grade 3 or 4 toxicity as defined by the CTCAE Version 5.0
Inability to stop antiplatelet and coumadin therapy for 7 days prior to and 7 days post treatment with the NanoKnife System
Tumor size not measurable
Known history of contrast allergy that cannot be medically managed
Known hypersensitivity to the metal in the electrodes (stainless steel 304L) that cannot be medically managed
Unable to be treated with a muscle blockade agent (e.g. pancuronium bromide, atracurium, cisatracurium, etc.)
Women who are pregnant or currently breast feeding
Women of childbearing potential who are not utilizing an acceptable method of contraception
Have taken an investigational agent within 30 days of visit 1
Have implanted cardiac pacemakers or defibrillators
Have implanted electronic devices or implants with metal parts in the vicinity of a lesion
Have a history of epilepsy or cardiac arrhythmia (atrial or ventricular fibrillation)
Have a recent history of myocardial infarction (within the past 2 months)
Have Q-T intervals greater than 550 ms unless treated with an Accysync Model 72 synchronization system controlling the NanoKnife system's output pulses
Evidence of distant metastases of stage IV
Have taken any chemotherapeutic agent within 5 weeks of treatment with the NanoKnife Irreversible Electroporation (IRE) System
Received non-conventional fractionation schedules, such as stereotactic radiation (5 fractions or less) or received higher than 54 Gray (Gy) delivered conventionally

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Englewood?

Yes, this clinical trial (NCT06937996) has an active research site in Englewood, NJ that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Pancreatic Cancer Non-resectable Treatment Options in Englewood, NJ

If you're searching for pancreatic cancer non-resectable treatment options in Englewood, NJ, this clinical trial (NCT06937996) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Englewood research site is actively enrolling participants for this clinical trial. You'll receive care from experienced pancreatic cancer non-resectable specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all pancreatic cancer non-resectable clinical trials near you to find additional studies recruiting in your area.

More Pancreatic Cancer Trials in Englewood, NJ

See all pancreatic cancer clinical trials recruiting in Englewood — not just this study.

Browse Pancreatic Cancer Trials in Englewood →

Browse More Trials by Condition

Pancreatic Cancer TrialsInterstitial Cystitis TrialsAll Conditions →

Ready to Join in Englewood?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Englewood, NJ